Combination therapy for the treatment of cancer
The present invention relates to a pharmaceutical combination comprising a PI3K/mTOR inhibitor selected from the compounds of Formula (I) (as described herein) or pharmaceutically acceptable salts or solvates thereof; and one or more anti-proliferative agents; pharmaceutical compositions containing...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
01.08.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a pharmaceutical combination comprising a PI3K/mTOR inhibitor selected from the compounds of Formula (I) (as described herein) or pharmaceutically acceptable salts or solvates thereof; and one or more anti-proliferative agents; pharmaceutical compositions containing said the compounds of Formula (I) and one or more anti-proliferative agents; and use of the said combination in the treatment of proliferative diseases or disorders. |
---|---|
Bibliography: | Application Number: TW20143115147 |